<code id='49696B3A09'></code><style id='49696B3A09'></style>
    • <acronym id='49696B3A09'></acronym>
      <center id='49696B3A09'><center id='49696B3A09'><tfoot id='49696B3A09'></tfoot></center><abbr id='49696B3A09'><dir id='49696B3A09'><tfoot id='49696B3A09'></tfoot><noframes id='49696B3A09'>

    • <optgroup id='49696B3A09'><strike id='49696B3A09'><sup id='49696B3A09'></sup></strike><code id='49696B3A09'></code></optgroup>
        1. <b id='49696B3A09'><label id='49696B3A09'><select id='49696B3A09'><dt id='49696B3A09'><span id='49696B3A09'></span></dt></select></label></b><u id='49696B3A09'></u>
          <i id='49696B3A09'><strike id='49696B3A09'><tt id='49696B3A09'><pre id='49696B3A09'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:8
          Cigna logo
          Julia Rendleman/Getty Images for Eventive Marketing

          Health insurer Cigna is paying more than $172 million to settle allegations that it committed fraud by knowingly submitting inaccurate diagnoses of its Medicare Advantage members, the company and Department of Justice announced Saturday.

          The settlement stems from a wide-ranging government investigation into the coding practices of Medicare Advantage insurers, as well as a specific whistleblower lawsuit against Cigna that the DOJ joined last year.

          advertisement

          That lawsuit alleged Cigna’s home visit program “regularly generated false and invalid diagnosis codes for certain serious, complex conditions that cannot be reliably diagnosed in a home setting and without extensive diagnostic testing or imaging,” the DOJ said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Was Amgen transparent enough on FDA's concern on cancer drug?
          Was Amgen transparent enough on FDA's concern on cancer drug?

          MarkJ.Terrill/APAmidthestunningrebukeAmgensufferedatthehandsoftheU.S.FoodandDrugAdministrationthiswe

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Health Care Service Corp to buy Cigna Medicare Advantage plans

          CignaisofficiallyexitingtheMedicarebusiness,agreeingtosellallofitsMedicareinsuranceplanstoHealthCare